International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett, F Barth, TI Bonner, G Cabral… - Pharmacological …, 2002 - ASPET
Two types of cannabinoid receptor have been discovered so far, CB1 (2.1: CBD: 1: CB1:),
cloned in 1990, and CB2 (2.1: CBD: 2: CB2:), cloned in 1993. Distinction between these …
cloned in 1990, and CB2 (2.1: CBD: 2: CB2:), cloned in 1993. Distinction between these …
[HTML][HTML] Role of endogenous cannabinoids in synaptic signaling
TF Freund, I Katona, D Piomelli - Physiological reviews, 2003 - journals.physiology.org
Freund, Tamás F., István Katona, and Daniele Piomelli. Role of Endogenous Cannabinoids
in Synaptic Signaling. Physiol Rev 83: 1017–1066, 2003; 10.1152/physrev. 00004.2003 …
in Synaptic Signaling. Physiol Rev 83: 1017–1066, 2003; 10.1152/physrev. 00004.2003 …
[HTML][HTML] The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis
DC D'Souza, E Perry, L MacDougall… - …, 2004 - nature.com
Recent advances in the understanding of brain cannabinoid receptor function have renewed
interest in the association between cannabinoid compounds and psychosis. In a 3-day …
interest in the association between cannabinoid compounds and psychosis. In a 3-day …
[PDF][PDF] Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a …
What is known and objective: Cannabidiol (CBD) is the main non-psychotropic component
of the Cannabis sativa plant. REM sleep behaviour disorder (RBD) is a parasomnia …
of the Cannabis sativa plant. REM sleep behaviour disorder (RBD) is a parasomnia …
The acute effects of cannabinoids on memory in humans: a review
M Ranganathan, DC D'Souza - Psychopharmacology, 2006 - Springer
Rationale Cannabis is one of the most frequently used substances. Cannabis and its
constituent cannabinoids are known to impair several aspects of cognitive function, with the …
constituent cannabinoids are known to impair several aspects of cognitive function, with the …
Cannabinoid receptors and their ligands
RG Pertwee, RA Ross - … , Leukotrienes and Essential Fatty Acids (PLEFA), 2002 - Elsevier
There are at least two types of cannabinoid receptors, CB1 and CB2, both coupled to G
proteins. CB1 receptors exist primarily on central and peripheral neurons, one of their …
proteins. CB1 receptors exist primarily on central and peripheral neurons, one of their …
Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine
E Valjent, JM Mitchell, MJ Besson… - British journal of …, 2002 - Wiley Online Library
Behavioural and pharmacological effects of Δ9‐tetrahydrocannabinol (THC) and nicotine
are well known. However, the possible interactions between these two drugs of abuse …
are well known. However, the possible interactions between these two drugs of abuse …
Effects of cannabinoids on neurotransmission
B Szabo, E Schlicker - Cannabinoids, 2005 - Springer
The CB 1 cannabinoid receptor is widely distributed in the central and peripheral nervous
system. Within the neuron, the CB 1 receptor is often localised in axon terminals, and its …
system. Within the neuron, the CB 1 receptor is often localised in axon terminals, and its …
The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
ET Tzavara, RJ Davis, KW Perry, X Li… - British journal of …, 2003 - Wiley Online Library
In order to explore potential therapeutic implications of cannabinoid antagonists, the effects
of the prototypical cannabinoid antagonist SR141716A on monoamine efflux from the …
of the prototypical cannabinoid antagonist SR141716A on monoamine efflux from the …
Modulatory effects of cannabinoids on brain neurotransmission
K Cohen, A Weizman… - European Journal of …, 2019 - Wiley Online Library
Recreational and chronic cannabis use has been associated with a range of acute and
chronic effects including; anti‐nociceptive actions, anxiety, depression, psychotic symptoms …
chronic effects including; anti‐nociceptive actions, anxiety, depression, psychotic symptoms …